Terapet’s New Investment Round of CHF 2,3 M
Today, we are pleased to announce the new investment of CHF 2,3 million as the first closing of the Pre-Series A investment round. This funding supports the commercialization of Terapet’s first product, Qualγscan and the development of new nuclear imaging products.
We would like to take this opportunity to thank all our investors, supporters and collaborators. Without your support and the great team behind Terapet, this wouldn’t have been possible.
Terapet SA Official Press Release:
Startupticker News: Link